Application of Proteomics in Cancer Gene Profiling: Two-Dimensional Difference in Gel Electrophoresis (2D-DIGE)

  • Deepak Hariharan
  • Mark E. Weeks
  • Tatjana Crnogorac-Jurcevic
Part of the Methods in Molecular Biology book series (MIMB, volume 576)


In the post-genomic era, proteomic strategies are at the forefront of cancer research. By studying the complement of all expressed genes, proteomics aims to provide knowledge of biomarkers indicative of the physiological state of cancer cells at a specific time, enabling screening, early diagnosis, monitoring the course of cancer development/progression, and gauging the efficacy and safety of novel therapeutic agents. Onco-proteomics thus has the ability to revolutionise oncology practice by delivering highly selective and individualised clinical care.

One of the proteomic techniques, two-dimensional (2D) difference in gel electrophoresis (DIGE) enables simultaneous examination and comparison of multiple samples using cyanine dyes to label amino acid residues that are then separated based on charge and mass. This technique reduces variability, improves reproducibility, and allows easier quantitation when compared with traditional 2D polyacrylamide gel electrophoresis (PAGE). These advantages combined with universal availability makes 2D-DIGE a first method of choice in cancer proteome analysis of diverse specimens, including tissues, cell lines, blood, and other body fluids.

Key words

Proteomics two-dimensional difference in gel electrophoresis 2D-DIGE Cancer 


  1. 1.
    Pastwa, E., Somiari, S. B., Czyz, M. and Somiari, R. I. (2007) Proteomics in human cancer research. Proteomics Clin Appl. 1(1), 4–17.CrossRefGoogle Scholar
  2. 2.
    O’Farrell, P. H. (1975) High resolution two-dimensional electrophoresis of proteins. J Biol Chem. 250, 4007–4021.PubMedGoogle Scholar
  3. 3.
    Unlu, M., Morgan, M. E. and Minden, J. S. (1997) Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis. 18, 2071–2077.CrossRefPubMedGoogle Scholar
  4. 4.
    Marouga, R., David, S. and Hawkins, E. (2005) The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal Bioanal Chem. 382, 669–678.CrossRefPubMedGoogle Scholar
  5. 5.
    Tonge, R., Shaw, J., Middleton, B., Rowlinson, R., Rayner, S., Young, J., et al. (2001) Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics. 1, 377–396.CrossRefPubMedGoogle Scholar
  6. 6.
    DeSouza, L., Diehl, G., Rodrigues, M. J., Guo, J., Romaschin, A. D., Colgan, T. J., et al. (2005) Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry. J Proteome Res. 4, 377–386.CrossRefPubMedGoogle Scholar
  7. 7.
    Ryu, O. H., Atkinson, J. C., Hoehn, G. T., Illei, G. G. and Hart, T. C. (2006) Identification of parotid salivary biomarkers in Sjogren’s syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis. Rheumatology (Oxford). 45, 1077–1086.CrossRefGoogle Scholar
  8. 8.
    Shaw, M. M. and Riederer, B. M. (2003) Sample preparation for two-dimensional gel electrophoresis. Proteomics. 3, 1408–1417.CrossRefPubMedGoogle Scholar
  9. 9.
    Orenes-Pinero, E., Corton, M., Gonzalez-Peramato, P., Algaba, F., Casal, I., Serrano, A., et al. (2007) Searching urinary tumor markers for bladder cancer using a two-dimensional differential gel electrophoresis (2D-DIGE) approach. J Proteome Res. 6, 4440–4448.CrossRefPubMedGoogle Scholar
  10. 10.
    Lee, I. N., Chen, C. H., Sheu, J. C., Lee, H. S., Huang, G. T., Yu, C. Y., et al. (2005) Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry. J Proteome Res. 4, 2062–2069.CrossRefPubMedGoogle Scholar
  11. 11.
    Katayama, M., Nakano, H., Ishiuchi, A., Wu, W., Oshima, R., Sakurai, J., et al. (2006) Protein pattern difference in the colon cancer cell lines examined by two-dimensional differential in-gel electrophoresis and mass spectrometry. Surg Today. 36, 1085–1093.CrossRefPubMedGoogle Scholar
  12. 12.
    Jin, T., Hu, L. S., Chang, M., Wu, J., Winblad, B. and Zhu, J. (2007) Proteomic identification of potential protein markers in cerebrospinal fluid of GBS patients. Eur J Neurol. 14, 563–568.CrossRefPubMedGoogle Scholar
  13. 13.
    Kakisaka, T., Kondo, T., Okano, T., Fujii, K., Honda, K., Endo, M., et al. (2007) Plasma proteomics of pancreatic cancer patients by multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis (2D-DIGE): up-regulation of leucine-rich alpha-2-glycoprotein in pancreatic cancer. J Chromatogr B Analyt Technol Biomed Life Sci. 852, 257–267.CrossRefPubMedGoogle Scholar
  14. 14.
    Gharbi, S., Gaffney, P., Yang, A., Zvelebil, M. J., Cramer, R., Waterfield, M. D., et al. (2002) Evaluation of two-dimensional differential gel electrophoresis for proteomic expression analysis of a model breast cancer cell system. Mol Cell Proteomics. 1, 91–98.CrossRefPubMedGoogle Scholar
  15. 15.
    Thiede, B., Hohenwarter, W., Krah, A., Mattow, J., Schmid, M., Schmidt, F., et al. (2005) Peptide mass fingerprinting. Methods. 35, 237–247.CrossRefPubMedGoogle Scholar
  16. 16.
    Aebersold, R. and Goodlett, D. R. (2001) Mass spectrometry in proteomics. Chem Rev. 101, 269–295.CrossRefPubMedGoogle Scholar

Copyright information

© Humana Press, a part of Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Deepak Hariharan
    • 1
  • Mark E. Weeks
    • 1
  • Tatjana Crnogorac-Jurcevic
    • 1
  1. 1.Cancer Research UK Molecular Oncology UnitBarts and The London Queen Mary’s School of Medicine and Dentistry, John Vane Science CentreLondonUK

Personalised recommendations